ProfileGDS4459 / ENSG00000075711
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 93% 93% 92% 89% 93% 94% 90% 93% 92% 90% 95% 94% 92% 91% 93% 88% 90% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.7493
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 27.5693
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.7492
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.7589
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.8893
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 68.1294
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.3490
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.8993
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.7292
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.2490
GSM623474group B, liver allograft wedge biopsie placebo treatment 18.3795
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.0194
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.6792
GSM623477group B, liver allograft wedge biopsie placebo treatment 47.3591
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.9493
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.9488
GSM623480group B, liver allograft wedge biopsie placebo treatment 77.1890